Therapeutic Removal of Uremic Toxins by Oral Sorbent

Uremic Toxins

Volumn , Issue , 2012, Pages 359-371

  Niwa, Toshimitsu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AST 120 effects on Klotho expression; AST 120 on CKD, CVD; AST 120 on indoxyl sulfate metabolism; Oral sorbent AST 120; Uremic toxin therapeutic removal by oral sorbent

Indexed keywords

EID: 84888660362     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118424032.ch23     Document Type: Chapter

References (40)

1. Niwa T, Yazawa T, Ise M, Sugano M, Kodama T, Uehara Y, Maeda K: Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 57:84-88, 1991.
2. Niwa T, Emoto Y, Maeda K, Uehara Y, Yamada N, Shibata M: Oral sorbent suppresses accumulation of albumin-bound indoxyl sulphate in serum of haemodialysis patients. Nephrol Dial Transplant 6:105-109, 1991.
3. Niwa T, Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994;124:96-104.
4. Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S: The protein metabolite hypothesis, a model for the progression of renal failure: An oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 52 (Suppl 62):S23-S28, 1997.
5. Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T: An oral sorbent reduces overload of indoxyl sulfate and gene expression of TGF-b1 in uremic rat kidneys. Nephrol Dial Transplant 15:1773-1781, 2000.
6. Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T: Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/ tandem mass spectrometry. J Chromatogr B 878:2997-3002, 2010.
7. Taki K, Niwa T: Indoxyl sulfate-lowering capacity of oral sorbents affects prognosis of kidney function and oxidative stress in chronic kidney disease. J Ren Nutr 17:48-52, 2007.
8. Tumur Z, Niwa T: An oral sorbent AST-120 increases renal NO synthesis in uremic rats. J Ren Nutr 18:60-64, 2008.
9. Adijiang A, Niwa T: An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats. Am J Nephrol 31:160-164, 2010.
10. Shimizu H, Bolati D, Adijiang A, Adelibieke Y, Muteliefu G, Enomoto A, Higashiyama Y, Higuchi Y, Nishijima F, Niwa T: Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of NF-kB. Am J Nephrol 33:319-324, 2011.
11. Shimizu H, Bolati D, Adijiang A, Enomoto A, Nishijima F, Dateki M, Niwa T: Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate. Am J Physiol Cell Physiol 299:C1110-C1117, 2010.
12. Shimizu H, Bolati D, Adijiang A, Muteliefu G, Enomoto A, Nishijima F, Dateki M, Niwa T: NF-kB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression and inhibition of proliferation in proximal tubular cells. Am J Physiol Cell Physiol 301:C1201-C1212, 2011.
13. Owada S, Maeba T, Sugano Y, Hirayama A, Ueda A, Nagase S, Goto S, Nishijima F, Bannai K, Yamato H: Spherical carbon adsorbent (AST-120) protects deterioration of renal function in chronic kidney disease rats through inhibition of reactive oxygen species production from mitochondria and reduction of serum lipid peroxidation. Nephron Exp Nephrol 115:e101-e111, 2010.
14. Palm F, Nangaku M, Fasching A, Tanaka T, Nordquist L, Hansell P, Kawakami T, Nishijima F, Fujita T: Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am J Physiol Renal Physiol 299:F380-F386, 2010.
15. Kawakami T, Inagi R, Wada T, Tanaka T, Fujita T, Nangaku M: Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress. Am J Physiol Renal Physiol 299:F568-F576, 2010.
16. Lee SH, Nam BY, Kang EW, Han SH, Li JJ, Kim do H, Kim SH, Kwak SJ, Park JT, Chang TI, Yoo TH, Han DS, Kang SW: Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy. Nephrol Dial Transplant 25:2134-2141, 2010.
17. Kim SH, Ghee JY, Piao S, Han DH, Song JH, Yoon HE, Choi BS, Kim J, Nishijima F, Obara K, Ishikawa N, Yang CW: Early and delayed effects of AST-120 on chronic cyclosporine nephropathy. Nephrol Dial Transplant 26:1502-1515, 2011.
18. Bolati D, Shimizu H, Higashiyama Y, Nishijima F, Niwa T: Indoxyl sulfate induces epithelial-to-mesenchymal transition in rat kidneys and human proximal tubular cells. Am J Nephrol 34:318-323, 2011.
19. Bolati D, Shimizu H, Niwa T: AST-120 ameliorates epithelial-to-mesenchymal transition and interstitial fibrosis in the kidneys of CKD rats. J Ren Nutr 22:176-180, 2012.
20. Iwasaki Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A, Motojima M, Fukagawa M: Administration of oral charcoal adsorbent (AST-120) suppresses lowturnover bone progression in uraemic rats. Nephrol Dial Transplant 21:2768-2774, 2006.
21. Schulman G, Agarwal R, Acharya M, Berl T, Blumenthal S, Kopyt N: A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 47:565-577, 2006.
22. Iida S, Kohno K, Yoshimura J, Ueda S, Usui M, Miyazaki H, Nishida H, Tamaki K, Okuda S: Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure. Clin Exp Nephrol 10:262-267, 2006.
23. Shoji T, Wada A, Inoue K, Hayashi D, Tomida K, Furumatsu Y, Kaneko T, Okada N, Fukuhara Y, Imai E, Tsubakihara Y: Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function. Nephron Clin Pract 105:c99-c107, 2007.
24. Yorioka N, Kiribayashi K, Naito T, Ogata S, Yokoyama Y, Kyuden Y, Ogawa T, Wada K, Hayashi K, Hirabayashi A: An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease. J Nephrol 21:213-220, 2008.
25. Konishi K, Nakano S, Tsuda S, Nakagawa A, Kigoshi T, Koya D: AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects. Diab Res Clin Pract 81:310-315, 2008.
26. Maeda K, Hamada C, Hayashi T, Shou I, Wakabayashi M, Fukui M, Horikoshi S, Tomino Y: Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure. J Int Med Res 37:205-213, 2009.
27. Akizawa T, Asano Y, Morita S, Wakita T, Onishi Y, Fukuhara S, Gejyo F, Matsuo S, Yorioka N, Kurokawa K: CAP-KD Study Group: Effect of a carbonaceous oral adsorbent on the progression of CKD-Amulticenter, randomized, controlled trial. Am J Kidney Dis 54:459-467, 2009.
28. Ueda H, Shibahara N, Takagi S, Inoue T, Katsuoka Y: AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. Ther Apher Dial 11:189-195, 2007.
29. Nakamura T, Sato E, Fujiwara N, Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamagishi S: Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation. Metabolism 60:260-264, 2011.
30. Namikoshi T, Tomita N, Satoh M, Sakuta T, Kuwabara A, Kobayashi S, Higuchi Y, Nishijima F, Kashihara N: Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy. Hypertens Res 32:194-200, 2009.
31. Fujii H, Nishijima F, Goto S, Sugano M, Yamato H, Kitazawa R, Kitazawa S, Fukagawa M: Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol Dial Transplant 24:2089-2095, 2009.
32. Yamamoto S, Zuo Y, Ma J, Yancey PG, Hunley TE, Motojima M, Fogo AB, Linton MF, Fazio S, Ichikawa I, Kon V: Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrol Dial Transplant 26:2491-2497, 2011.
33. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Shimada N, Ebihara I, Koide H: Oral ADSORBENTAST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure. Kidney Blood Press Res 27:121-126, 2004.
34. Ueda H, Shibahara N, Takagi S, Inoue T, Katsuoka Y: AST-120 treatment in predialysis period affects the prognosis in patients on hemodialysis. Ren Fail 30:856-860, 2008.
35. Shibahara H, Shibahara N: Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD. J Nephrol 23:535-540, 2010.
36. Yu M, Kim YJ, Kang DH: Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 6:30-39, 2011.
37. Nakai K, Fujii H, Kono K, Goto S, Fukagawa M, Nishi S: Effects of AST-120 on left ventricular mass in predialysis patients. Am J Nephrol 33:218-223, 2011.
38. Niwa T: Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 20 (Suppl 1):S2-S6, 2010.
39. Niwa T: Uremic toxicity of indoxyl sulfate. Nagoya J Med Sci 72:1-11, 2010.
40. Niwa T, Shimizu H: Indoxyl sulfate induces nephrovascular senescence. J Ren Nutr 22:102-106, 2012.